Katie Hobbins

Social media is a great way to gain exposure, but there are many dos-and-don’ts to understand when signing up for a social platform.

The FDA approved the pneumococcal 15-valent conjugate vaccine for the prevention of invasive pneumococcal disease in infants and children.

The FDA announced the EUA of both Moderna and Pfizer-BioNTech COVID-19 vaccines for use in children aged 6 months and older.

GSK plc announced FDA approval of the PRIORIX vaccine for prevention of measles, mumps, and rubella.

Pfizer-BioNTech reports strong immune response, high efficacy, and favorable safety in third dose of the COVID-19 vaccine.

The proposed aid bill would give the FDA funds to increase staff and prepare for future infant formula shortages.

This week, the agency announced it is encouraging importation of infant formula from usually unutilized foreign means in hopes of increasing access to the product in the wake of the country-wide shortage.

Parents are on edge as the formula shortage worsens across the United States. Pediatricians, the AAP, and White House advise on available options.

At AAD, one researcher shared the potential risks of antibiotic resistance in acne management.

Patients on testosterone for masculinizing hormone therapy are at an increased risk of acne due to both inside and outside factors. Matthew David Mansh, MD, FAAD, explains his process for treating these patients.

AbbVie announced the approval after 3 studies show the efficacy and safety of upadacitinib using mono- and combination therapy.